|
IL-13 Blocker Helps Asthma Control
MedPage Today Explain that asthma patients with poorly controlled symptoms on inhaled steroids had significant improvement in lung function during 12 weeks of treatment with an investigational interleukin-13 (IL-13) … Experimental Drug Promising Against Tough-to-Treat Asthma Roche asthma drug shows promise in mid-stage trial Roche's Lebrikizumab Improved Lung Function in Asthma Study |
View full post on asthma – Google News